Literature DB >> 19826503

Lacosamide: what can be expected from the next new antiepileptic drug?

Bassel W Abou-Khalil.   

Abstract

Entities:  

Year:  2009        PMID： 19826503      PMCID： PMC2759042          DOI： 10.1111/j.1535-7511.2009.01317.x

Source DB:  PubMed          Journal:  Epilepsy Curr        ISSN： 1535-7511            Impact factor:   7.500


× No keyword cloud information.
  8 in total

1.  Lacosamide in painful diabetic peripheral neuropathy: a phase 2 double-blind placebo-controlled study.

Authors:  Richard L Rauck; Aziz Shaibani; Victor Biton; Jeff Simpson; Brigitte Koch
Journal:  Clin J Pain       Date:  2007-02       Impact factor: 3.442

2.  Adjunctive lacosamide for partial-onset seizures: Efficacy and safety results from a randomized controlled trial.

Authors:  Péter Halász; Reetta Kälviäinen; Maria Mazurkiewicz-Beldzińska; Felix Rosenow; Pamela Doty; David Hebert; Timothy Sullivan
Journal:  Epilepsia       Date:  2009-01-17       Impact factor: 5.864

3.  Lacosamide in painful diabetic neuropathy: an 18-week double-blind placebo-controlled trial.

Authors:  Aziz Shaibani; Salah Fares; Jean-Louis Selam; Armen Arslanian; Jeffrey Simpson; David Sen; Sabine Bongardt
Journal:  J Pain       Date:  2009-05-05       Impact factor: 5.820

4.  Efficacy and safety of lacosamide in diabetic neuropathic pain: an 18-week double-blind placebo-controlled trial of fixed-dose regimens.

Authors:  James P Wymer; Jeffrey Simpson; David Sen; Sabine Bongardt
Journal:  Clin J Pain       Date:  2009-06       Impact factor: 3.442

Review 5.  Lacosamide: pharmacology, mechanisms of action and pooled efficacy and safety data in partial-onset seizures.

Authors:  Ahmad Beydoun; Joseph D'Souza; David Hebert; Pamela Doty
Journal:  Expert Rev Neurother       Date:  2009-01       Impact factor: 4.618

Review 6.  Lacosamide: a review of preclinical properties.

Authors:  Bettina K Beyreuther; Joachim Freitag; Cara Heers; Niels Krebsfänger; Ute Scharfenecker; Thomas Stöhr
Journal:  CNS Drug Rev       Date:  2007

7.  The investigational anticonvulsant lacosamide selectively enhances slow inactivation of voltage-gated sodium channels.

Authors:  Adam C Errington; Thomas Stöhr; Cara Heers; George Lees
Journal:  Mol Pharmacol       Date:  2007-10-16       Impact factor: 4.436

8.  Efficacy and safety of oral lacosamide as adjunctive therapy in adults with partial-onset seizures.

Authors:  Elinor Ben-Menachem; Victor Biton; Dalius Jatuzis; Bassel Abou-Khalil; Pamela Doty; G David Rudd
Journal:  Epilepsia       Date:  2007-07       Impact factor: 5.864
  8 in total
  1 in total

1.  Newer anticonvulsant medications in pediatric neurology.

Authors:  Michael M Quach; Abdul Mazin; James J Riviello
Journal:  Curr Treat Options Neurol       Date:  2010-11       Impact factor: 3.598
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.